文献速递艾滋病与性传播感染

HIV感染者肾功能快速进展:多基因与D:A:D风险评分的应用

Rapid Progression of Kidney Dysfunction in People Living With HIV: Use of Polygenic and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Risk Scores.
PubMed 文献 · J Infect Dis · 2021-01-01

在瑞士HIV队列研究的白人参与者中,评估多基因风险评分和D:A:D慢性肾病风险评分与肾功能快速进展的关联。多变量分析显示,高D:A:D风险、多基因风险评分第四四分位及近期富马酸替诺福韦二吡呋酯暴露均与快速进展相关。

要点

  • 高D:A:D风险者肾功能快速进展风险增加(HR=1.82)。
  • 多基因风险评分第四四分位与快速进展相关(HR=2.04)。
  • 近期富马酸替诺福韦二吡呋酯暴露与快速进展相关(HR=1.36)。

核心结论

  • 多基因风险评分与瑞士HIV感染者肾功能快速进展相关,需结合临床和抗逆转录病毒风险因素分析。

研究设计与样本

  • 基于瑞士HIV队列研究白人参与者的分析,纳入225例快速进展者和3378例无快速进展者。

主要发现

  • 高D:A:D风险者快速进展HR=1.82(95%CI 1.28-2.60)。
  • 多基因风险评分第二、三、四四分位快速进展HR分别为1.39(95%CI 0.94-2.06)、1.52(95%CI 1.04-2.24)、2.04(95%CI 1.41-2.94)。
  • 近期富马酸替诺福韦二吡呋酯暴露快速进展HR=1.36(95%CI 1.06-1.76)。

临床怎么用

  • 可考虑结合D:A:D风险评分和多基因风险评分识别肾功能快速进展高风险HIV感染者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In people with human immunodeficiency virus (PWH), it is unknown whether genetic background associates with rapid progression of kidney dysfunction (ie, estimated glomerular filtration rate [eGFR] decrease of >5mL/min/1.73m2 per year for ≥3 consecutive years). METHODS: We obtained univariable and multivariable hazard ratios (HR) for rapid progression, based on the clinical D:A:D chronic kidney disease (CKD) risk score, antiretroviral exposures, and a polygenic risk score based on 14 769 genome-wide single nucleotide polymorphisms in white Swiss HIV Cohort Study participants. RESULTS: We included 225 participants with rapid progression and 3378 rapid progression-free participants. In multivariable analysis, compared to participants with low D:A:D risk, participants with high risk had rapid progression (HR = 1.82 [95% CI, 1.28-2.60]). Compared to the first (favorable) polygenic risk score quartile, participants in the second, third, and fourth (unfavorable) quartiles had rapid progression (HR = 1.39 [95% CI, 0.94-2.06], 1.52 [95% CI, 1.04-2.24], and 2.04 [95% CI, 1.41-2.94], respectively). Recent exposure to tenofovir disoproxil fumarate was associated with rapid progression (HR = 1.36 [95% CI, 1.06-1.76]). DISCUSSION: An individual polygenic risk score is associated with rapid progression in Swiss PWH, when analyzed in the context of clinical and antiretroviral risk factors.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Dietrich LG, Thorball CW, Ryom L, et al. Rapid Progression of Kidney Dysfunction in People Living With HIV: Use of Polygenic and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Risk Scores. J Infect Dis. 2021. PMID: 33151293. doi:10.1093/infdis/jiaa695

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。